At the tumor T cell level, there was a significant increase in CD4+ cells and CD8+ cells (Fig. 7Q and R), as well as activated IFN-γ+CD8+ T cells (Fig. 7S and T) in the combination therapy group. The gene discussed is CD4; the disease is neoplasm.